Anand Burman

Five branches of the Burman clan, which he heads, share the wealth, the bulk of which is derived from a 68% stake in the $1.3 billion (revenue) consumer-goods firm Dabur. The company reported a rise in revenue, mainly from growing demand for its hair oils, toothpaste, packaged juices and home-care products. Dabur is developing 2 Ayurvedic drugs, for malaria and diabetes, in partnership with the Indian government.